CODEX: Choose CODEX for a cutting-edge future in the Ethereum blockchain and beyond!
January 08, 2024 18:00 ET
|
CODEX
Madrid, Spain, Jan. 08, 2024 (GLOBE NEWSWIRE) -- In the ever-expanding world of cryptocurrencies, CODEX emerges as a game-changer, offering a suite of services that redefine how we engage with...
Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits
November 22, 2021 08:03 ET
|
Codex
San Diego, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, and RNAimmune, a leading biotech company with expertise in...
MEDIA ALERT: Codex DNA Customer to Highlight Advantages of Automated BioXp™ System in Precision Cancer Immunotherapy Applications at 13th Annual PEGS Europe Protein and Antibody Engineering Summit
November 01, 2021 08:03 ET
|
Codex
San Diego, CA, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that one of its customers will be...
Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant
September 01, 2021 16:15 ET
|
Codex
San Diego, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of its first full-length...
Codex DNA Releases Long Gene Fragment Cloning On The BioXp™ System
May 04, 2021 10:00 ET
|
Codex
San Diego, CA, May 04, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, announced the...
Codex DNA Expands End-to-End Automated Synthetic Biology Workstation Enabling High Throughput Synthesis from DNA Sequence to Biologically Active mRNA
April 27, 2021 10:00 ET
|
Codex
San Diego, CA, April 27, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today...
Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants
March 10, 2021 10:00 ET
|
Codex
San Diego, March 10, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., today announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The...
Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19
December 01, 2020 10:15 ET
|
Codex
San Diego, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc. today announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and...
Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
August 25, 2020 10:24 ET
|
Codex
San Diego, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, today announced critical advancements in its...
Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use
August 18, 2020 09:15 ET
|
Codex
San Diego, Aug. 18, 2020 (GLOBE NEWSWIRE) -- The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical...